PiscitelliSCDanzigerLHRodvoldKA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm1992; 11: 137–52.
2.
BachmannKSchwartzJIForneyRFrogameniAJaureguiLE. The effect of erythromycin on the disposition kinetics of warfarin. Pharmacology1984; 28: 171–6.
3.
WeibertRTLorentzSMTownsendRJCookCEKlauberMRJaggerPI. Effect of erythromycin in patients receiving long-term warfarin therapy. Clin Pharm1989; 8: 210–4.
4.
SlaughterRLEdwardsDJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother1995; 29: 619–24.
5.
HopkinsS. Clinical toleration and safety of azithromycin. Am J Med1991; 91 (suppl 3A): 40S–5S.
6.
AmacherDESchomakerSJRetsemaJA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P450. Antimicrob Agents Chemother1991; 35: 1186–90.
7.
GasconMPDayerP. Comparative effects of macrolide antibiotics on liver monooxygenases (abstract). Clin Pharmacol Ther1991; 49: 158.
8.
LjuticDRumboldtZ. Possible interaction between azithromycin and cyclosporin: a case report (letter). Nephron1995; 70: 130.
9.
CorriganJJ. The effect of vitamin E on warfarin-induced vitamin K deficiency. Ann N Y Acad Sci1982; 334: 361–8.